Aetion® Discover helps define and understand populations, outcomes, treatments and trends of interest.
NEW YORK, May 8, 2023 /PRNewswire/ — Aetion®, a global leader in real-world evidence analysis and technology, today announced the launch of Aetion® Discover, a new application for exploratory analysis. The application provides users with an intuitive interface to rapidly generate hypotheses and insights throughout the biopharmaceutical and medical technology life cycle. As with Aetion® Substantiate, also based on the Aetion Evidence Platform®, Discover drives results that are fast, reliable and scalable.
When developing and commercializing assets, scientists, technologists, and analysts are looking for faster and easier ways to understand large longitudinal data sets and the information they contain. With Discover, users can view, evaluate, and select data sets for their specific analytics goal. Within and between data sets, users can define and describe populations of interest, and obtain and interpret results on any number of mission- and work-critical questions, such as generating hypotheses related to label expansion.
Discover was exclusively designed to offer:
“Time and time again, we’ve heard interest from our customers in extending our technology into ‘everyday information,’ and more importantly, that this [visual] exploration work easily extends to advanced evidence generation when necessary.” necessary,” said Dr. Jeremy Rassen, Aetion’s president, co-founder and CTO. “We are excited to bring our software to a broader set of use cases, to create essential insights and efficiencies across all user groups. Like all Aetion offerings, Discover is based on the latest and best science and is powered by a wide range of real-world data.”
Discover is fully compatible with Substantiate, Aetion’s application for normative-grade causal and descriptive analyses. Discover and Substantiate are based on Aetion’s core technology platform, the Aetion Evidence Platform.
Aetion Discover pre-sale and demos begin today at ISPOR 2023. For more information, visit aetion.com/discover.
About Aetion®Aetion is a healthcare testing company that provides real-world evidence to manufacturers, purchasers and regulators of medical technologies and treatments. The Aetion Evidence Platform® analyzes real-world data to produce transparent, fast, and scientifically validated answers about safety, efficacy, and value. Founded by Harvard Medical School faculty with decades of experience in epidemiology and health outcomes research, Aetion informs healthcare’s most critical decisions—what works best, for whom, and when—to guide product development, marketing and innovation in payments. For more information, visit aetion.com and follow us on LinkedIn.
Logo – https://mma.prnewswire.com/media/664868/…
View original content: https://www.prnewswire.com/news-releases/aetion-lanza-una-nueva-aplicacion-de-analisis-descriptivo-e-informacion-rapida-y-fiable-301817976.html
